Health Law & Policy

The Food Is Medicine Advocacy Toolkit: Using Advocacy to Expand Opportunities for Food and Nutrition Services in Public and Private Healthcare Systems

Webinar – The Food Is Medicine Advocacy Toolkit: Using Advocacy to Expand Opportunities for Food and Nutrition Services in Public and Private Healthcare Systems Time and Date: Wednesday, August 17, 2:00-3:30 pm EST Presenters:  Sarah Downer, Clinical Instructor, The Center for Health Law and Policy Innovation at Harvard Law School Karen Pearl, President & CEO, God’s […]

A cure at what cost? More states easing restrictions on Hepatitis C treatments

Originally published by NewsWorks, the online home of WHYY on August 11, 2016. Written by Elana Gordon. For years, Valerie Green just wasn’t feeling right. She was in a constant state of fatigue but couldn’t figure out what was going on. Neither could doctors. That was until a specialist ran a series of blood tests last year, […]

CHLPI Faculty Director Quoted in Oregon Bulletin on HCV Article

An August 8, 2016 article titled “A cure for hepatitis C, if not for the cost” provides an in-depth look into the lives of various individuals living with Hepatitis C (HCV), as well as some who have been able to access the HCV cure. The article, published by The Bulletin in Oregon, features interviews with […]

Striving For Equity In Access To And Use Of Specialty Care

The Center for Health Law and Policy Innovation’s Specialty Care initiative was included in an August 1, 2016 blog post on healthaffairsblog.com. The piece looks at grantees selected by the Bristol-Myers Squibb Foundation to address inequities in access to, and utilization of, specialty care services in the United States. The blog post defines the goal of the initiative to […]

Boston Globe Editorial Board Calls for Wider Access to Hepatitis C Drugs

A July 29, 2016 piece from the Boston Globe’s editorial board calls for wider access to Hepatitis C (HCV) curative drugs. “Wider access to hepatitis C drugs is humane and pragmatic” highlights recent changes in Massachusetts and the MassHealth Medicaid program as the first step in eradicating HCV, and goes on to call for public education […]

CHLPI Litigation Director Quoted in Motley Fool on Hepatitis C Drug Pricing

Originally written by Cheryl Swanson for The Motley Fool. Is your stomach ready for a big twist? Then you should know that the escalating battle over drug prices just got turned on its head. For the past couple of years, states and insurers have successfully blocked patient access to many game-changing drugs because of their sky-high […]

CHLPI Submits Comments on MassHealth 1115 Waiver Proposal

On July 15, 2016, CHLPI submitted two comment letters to Massachusetts’ Executive Office of Health & Human Services (EOHHS) regarding its proposal to amend the state Medicaid program’s (MassHealth’s) Section 1115 Demonstration Waiver. Under the proposed waiver, MassHealth will transition away from siloed fee-for-service care by establishing provider-led Accountable Care Organizations (ACOs). These ACOs will […]

New Guidance from the Public Health Institute and CDC on Food System Assessments Directs Hospital Staff to CHLPI Food Bank Resource

On July 22, 2016, the Tackling Hunger Project, a partnership between the Public Health Institute and the Centers for Disease Control and Prevention, released Making Food Systems Part of Your Community Health Needs Assessment: Practical Guidance from the TACKLING HUNGER Project. The Guide offers practical tools to hospitals on how to incorporate an assessment of […]

CHLPI’s Litigation Director Quoted in Article on HCV Medication Access

A July 2, 2016 article from Judith Graham looks at the recent wave of state Medicaid programs to increase access to Hepatitis C medications in the light of potential litigation from the Center for Health Law and Policy Innovation, its partners, and other organizations. “Help with the high cost of hepatitis C drugs,” which ran […]

State lowers requirements for MassHealth patients to get hepatitis C drugs

Originally published in Boston Business Journal on July 1, 2016 by Jessica Bartlett. For half a million patients on MassHealth, access to hepatitis C-curing drugs has been limited. The state has required MassHealth patients, who were being cared for on a budgeted basis, to have severe liver damage in order to qualify to receive the […]